FSTL1 and ovarian carcinoma: Overexpression of FSTL1 was associated with poor prognosis of glioblastoma [11] and favored the progression of prostate cancer [12]; its inactivation in colon, stomach, breast, kidney, lung, endometrial and ovarian cancers suggests a function as a putative tumor suppressor gene [5, 13–15].